Search Our Website:
menu
Mythili Markowski, Ph.D.
BIPC Logo

Mythili Markowski, Ph.D.

Counsel

P: 202 452 7314
Washington, DC
Newark, NJ
 
 
DOWNLOAD vCARD
PRINT MY BIO
  • Representative USPTO Litigation Matters:
    • 3Shape A/S v. Align Technology, Inc., IPR2020-00173, USPTO Patent Trial and Appeal Board
    • 3Shape A/S v. Align Technology, Inc., IPR2020-00174, USPTO Patent Trial and Appeal Board
    • Cobham Mission Systems Davenport LSS Inc. v. L’Air Liquide, IPR2020-005220, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, IPR2018-00195, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, IPR2018-00196, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, IPR2018-00197, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, IPR2018-00198, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, PGR2018-00103, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, PGR2018-00104, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, IPR2018-00117, USPTO Patent Trial and Appeal Board
    • Align Technology, Inc. v. 3Shape A/S, IPR2018-00118, USPTO Patent Trial and Appeal Board
    • Ariosa Diagnostics v. Isis Innovation Limited, IPR2012-00022 and IPR2014-00390, USPTO Patent Trial and Appeal Board
    • The Broad Institute, Inc., et al. v. The Regents of the University of California, et al., Patent Interference 106,048
    • Anderson v. Wan, Patent Interference 106,002
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01323, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,629,131)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01322, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,604,012)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01320, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,604,013)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01319, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,614,204)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01318, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,609,646)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01315, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,466,172)
    • Phigenix, Inc. v. Immunogen, IPR2014-00676, USPTO Patent Trial and Appeal Board
    • Apotex Inc. v. Alcon Pharmaceuticals Ltd., IPR2012-00012 and IPR2013-00015, USPTO Patent Trial and Appeal Board
    • exocad GmbH et al. v. 3Shape A/S, IPR2018-00785, USPTO Patent Trial and Appeal Board
    • exocad GmbH et al. v. 3Shape A/S, IPR2018-00788, USPTO Patent Trial and Appeal Board
    • 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00154, USPTO Patent Trial and Appeal Board
    • 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00155, USPTO Patent Trial and Appeal Board
    • 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00156, USPTO Patent Trial and Appeal Board
    • 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00157, USPTO Patent Trial and Appeal Board
    • 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00159, USPTO Patent Trial and Appeal Board
    • 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00160, USPTO Patent Trial and Appeal Board
    • 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00163, USPTO Patent Trial and Appeal Board
    • Velasco Diez v. McAllister, Patent Interference 106,103
  • Representative District Court Litigation Matters:
    • Align Technology, Inc. v. 3Shape A/S et al. Civil Action Nos. 1-17-cv-01646, 1-17-cv-01647 (D.Del.)
    • 3Shape A/S v. Align Technology, Inc. Civil Action Nos. 1-18-cv-00853, 1-18-cv-00886 (D.Del.)
    • Alcon Pharmaceuticals Ltd. et al. v. Apotex Inc. et al., (D. Del.) (related IPR2012-00012 and IPR2013-00015 before the USPTO PTAB)
    • Fresenius Medical Care Holdings, Inc. v. Amneal Pharmaceuticals, LLC, (D. Mass.)
    • Galderma Laboratories Inc. et al. v. Amneal Pharmaceuticals LLC, (D. Del.)
    • Reckitt Benckiser LLC et al. v. Amneal Pharmaceuticals, LLC, (D.N.J.)
    • Shire LLC et al. v. Sandoz Inc., (D.N.J.)
    • H. Lundbeck A/S et al. v. MSN Laboratories Private Limited et al. Civil Action No.: 1-18-cv-00114 (District of Delaware) – Challenging patents on vortioxetine
    • Forest Laboratories, LLC f\/k\/a Forest Laboratories, Inc. et al v. MSN Laboratories Private Limited et al. Civil Action No.: 2-17-cv-10140 (District of New Jersey) – Challenging patents on levomilnacipran
    • Merck Sharp & Dohme Corp. v. MSN Laboratories Private Limited et al. Civil Action No.: 3-18-cv-00675 (District of New Jersey) – Challenging patent on fosaprepitant